Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Carbamazepine Versus Phenobarbitone Monotherapy for Epilepsy: an Individual Participant Data Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435906/all/images/repview. Accessed 20 May 2024.
Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435906/all/images/repview. Accessed May 20, 2024.
Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435906/all/images/repview
Carbamazepine Versus Phenobarbitone Monotherapy for Epilepsy: an Individual Participant Data Review [Internet]. In: Cochrane Abstracts. [cited 2024 May 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435906/all/images/repview.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review
ID - 435906
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435906/all/images/repview
DB - Evidence Central
DP - Unbound Medicine
ER -